OTTAWA, Oct. 31 /CNW Telbec/ - Safe and Sound, Optimizing Prescribing
Behaviours, a new report from the Health Council of Canada, makes an important
contribution to the on-going dialogue in Canada regarding the optimal use of
drugs, said Canadian Agency for Drugs and Technologies in Health (CADTH)
President and Chief Executive Officer Dr. Jill Sanders.
Based on a June 2007 policy symposium organized by the Health Council of
Canada, the report summarizes the positions of stakeholders and experts of a
range of themes related to safe and effective use of pharmaceuticals. CADTH
contributed to the policy symposium.
"By presenting what was heard from many different groups -- consumers,
the research community, government and health care delivery organizations -
Optimizing Prescribing Behaviours provides a valuable blueprint for future
action to advance optimal prescribing in Canada," said Sanders.
The report calls for further action in three areas:
1. education and information for patients and prescribers, so that
prescribing decisions are more likely to be safe and sound and
patients are more likely to receive the most appropriate prescription;
2. the policies and legislation that govern the Canadian medication-use
3. the electronic health record.
Barb Shea, Vice President of CADTH's Canadian Optimal Medication
Prescribing and Utilization Service (COMPUS) said "I am gratified that the
report endorses the strategic direction we are taking with COMPUS,
particularly since the report reflects the views of so many different groups.
Coupled with the recent comments from Dr. Brian Day, President of the Canadian
Medical Association - who referenced the 'excellent preliminary work of
COMPUS', the Health Council's report shows that we are on the right path."
Shea also endorsed the report's focus on academic detailing and patient
and public education. She said that COMPUS has supported and will continue to
support the work of academic detailing initiatives across Canada. The
initiatives are important conduits for the dissemination of COMPUS work.
The report can be downloaded at
The Canadian Agency for Drugs and Technologies in Health (CADTH) is a
national body that provides Canada's federal, provincial, and territorial
health care decision makers with credible, impartial advice and evidence-based
information about the effectiveness and efficiency of drugs and other health
The Canadian Optimal Medication Prescribing and Utilization Service
(COMPUS), funded by Health Canada, is a program of CADTH. COMPUS identifies
and promotes evidence-based, clinical and cost-effectiveness information on
optimal drug prescribing and use. User-friendly tools are provided to health
care providers and consumers to encourage the use of this information.
For further information:
For further information: visit www.cadth.ca or contact: Janet Crain,
Senior Communications Advisor, Canadian Agency for Drugs and Technologies in
Health, (613) 226-2553, email@example.com